Live Breaking News & Updates on Director Yadin Rozov

Stay updated with breaking news from Director yadin rozov. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Insider Buying: Neo Performance Materials Inc. (TSE:NEO) Director Buys 8,900 Shares of Stock

Insider Buying: Neo Performance Materials Inc. (TSE:NEO) Director Buys 8,900 Shares of Stock
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Stifel Nicolaus , Raymond James , Yadin Rozov , Neo Performance Materials Inc , Neo Performance Materials , Get Free Report , Director Yadin Rozov , Performance Materials , Performance Materials Inc , Neo Performance Materials Daily ,

Landscape Capital Management L.L.C. Acquires New Stake in Oramed Pharmaceuticals Inc. (NASDAQ:ORMP)

Landscape Capital Management L.L.C. acquired a new position in shares of Oramed Pharmaceuticals Inc. (NASDAQ:ORMP – Get Rating) in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor acquired 26,220 shares of the biotechnology company’s stock, valued at approximately $315,000. Landscape Capital Management L.L.C. owned […] ....

Yadin Rozov , Nadav Kidron , Renaissance Technologies , Oramed Pharmaceuticals , Quarter For Oramed Pharmaceuticals , Oramed Pharmaceuticals Profile , Millennium Management , Blackrock Inc , Oramed Pharmaceuticals Inc , Securities Exchange Commission , Lindbrook Capital , Oramed Pharmaceuticals Trading Down , News Ratings For Oramed Pharmaceuticals Daily , Get Rating , Street Corp , Director Yadin Rozov , Exchange Commission , Pharmaceuticals Trading Down , Visit Holdingschannel , Oramed Pharmaceuticals Daily , Nasdaq Ormp , Sec Filings , Hedge Fund Holdings , Institutional Investor Holdings ,

Oramed Pharmaceuticals (NASDAQ:ORMP) Shares Cross Below 200 Day Moving Average of $4.88

Oramed Pharmaceuticals Inc. (NASDAQ:ORMP – Get Rating) shares passed below its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $4.88 and traded as low as $2.81. Oramed Pharmaceuticals shares last traded at $3.03, with a volume of 740,289 shares trading hands. Wall Street Analyst Weigh In ORMP […] ....

Hong Kong , Yadin Rozov , Nadav Kidron , Janney Montgomery Scott , Cantor Fitzgerald , Oramed Pharmaceuticals Inc , News Ratings For Oramed Pharmaceuticals Daily , Hong Kong Ltd , Oramed Pharmaceuticals , Advisor Group , Oramed Pharmaceuticals Stock Down , Securities Exchange Commission , Canaccord Genuity Group , Get Rating , Genuity Group , Pharmaceuticals Stock Down , Exchange Commission , Director Yadin Rozov , Kong Ltd , Jacobson Investment Advisors , Oramed Pharmaceuticals Daily , Nasdaq Ormp ,

Oramed Pharmaceuticals (NASDAQ:ORMP) Rating Increased to Hold at StockNews.com

StockNews.com upgraded shares of Oramed Pharmaceuticals (NASDAQ:ORMP – Get Rating) from a sell rating to a hold rating in a report issued on Tuesday morning. Other analysts have also recently issued research reports about the stock. Canaccord Genuity Group cut shares of Oramed Pharmaceuticals from a buy rating to a hold rating and cut their […] ....

Nadav Kidron , Yadin Rozov , Managers Group , Oramed Pharmaceuticals Inc , Securities Exchange Commission , Capital Management , Oramed Pharmaceuticals Stock , Oramed Pharmaceuticals , Canaccord Genuity Group , Cantor Fitzgerald , News Ratings For Oramed Pharmaceuticals Daily , Oramed Pharmaceuticals Company Profile , Institutional Trading Of Oramed Pharmaceuticals , Altshuler Shaham Ltd , Marshall Wace , Get Rating , Genuity Group , Exchange Commission , Director Yadin Rozov , Shaham Ltd , Oramed Pharmaceuticals Daily , Nasdaq Ormp , Stocknews Com ,

Short Interest in Oramed Pharmaceuticals Inc. (NASDAQ:ORMP) Drops By 19.9%

Oramed Pharmaceuticals Inc. (NASDAQ:ORMP – Get Rating) saw a significant decline in short interest in the month of March. As of March 31st, there was short interest totalling 789,300 shares, a decline of 19.9% from the March 15th total of 985,700 shares. Based on an average trading volume of 1,690,000 shares, the days-to-cover ratio is […] ....

Hong Kong , Nadav Kidron , Yadin Rozov , Canaccord Genuity Group , Cantor Fitzgerald , News Ratings For Oramed Pharmaceuticals Daily , Oramed Pharmaceuticals , Oramed Pharmaceuticals Inc , Advisor Group , Hong Kong Ltd , Janney Montgomery Scott , Hedge Funds Weigh In On Oramed Pharmaceuticals , Oramed Pharmaceuticals Stock Performance , Get Rating , Director Yadin Rozov , Kong Ltd , Jacobson Investment Advisors , Oramed Pharmaceuticals Daily , Nasdaq Ormp ,